Sign in
Taking people in NetherlandsPhase 1

Skin-Injected Immunotherapy Pilot Study for Cervical Cancer Patients

A early-stage study testing an immunotherapy given under the skin in adults with cervical cancer.

Key facts

Who runs it
Universitair Medisch Centrum Groningen
Where
Groningen, NetherlandsSee the site
Registry title
Pilot Study on Subcutaneously Administered Immunotherapy for the Treatment of Cervical Cancer
Status
Recruiting
Phase
Phase 1
People taking part
12 people, planned
Started
5 Jan 2026
Expected to end
2 Mar 2027
Type of study
Interventional
Record updated
19 August 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adult women with cervical cancer. It tests an immunotherapy given as an injection under the skin.

Age
18 years or older
Sex
Women only

Where in Netherlands

  • Universitair Medisch Centrum GroningenGroningen, NetherlandsTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record

Print a page for my doctor

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).
Plain-language title
Skin-Injected Immunotherapy Pilot Study for Cervical Cancer PatientsGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 9 November 2026.
Record updated
19 August 2025